Search
Patexia Research
Case number 1:22-cv-03610

EISAI CO., LTD. et al v. AUROBINDO PHARMA LTD. et al > Documents

Date Field Doc. No.Description (Pages)
Jun 13, 2022 6 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of EISAI CO., LTD., EISAI INC., NOVARTIS PHARMA AG (LOWER, J.)
Jun 10, 2022 4 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent/Trademark Form filed. (jab)
Jun 10, 2022 5 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jab)
Jun 8, 2022 N/A Add and Terminate Judges (0)
Docket Text: Judge Christine P. O'Hearn and Magistrate Judge Ann Marie Donio added. (dmw)
Jun 8, 2022 1 Main Document (7)
Docket Text: COMPLAINT against AUROBINDO PHARMA LTD., AUROBINDO PHARMA USA, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-13472715) , Related Case Selected, filed by EISAI CO., LTD., NOVARTIS PHARMA AG, EISAI INC.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) L. Civ. R. 11.2 & 40.1 Certification)(DENI, WILLIAM)
Jun 8, 2022 1 Exhibit A (9)
Jun 8, 2022 1 Civil Cover Sheet (1)
Jun 8, 2022 1 L. Civ. R. 11.2 & 40.1 Certification (1)
Jun 8, 2022 2 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by EISAI CO., LTD., EISAI INC.. (DENI, WILLIAM)
Jun 8, 2022 3 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by NOVARTIS PHARMA AG. (DENI, WILLIAM)
Jun 8, 2022 1 Complaint* (1)
Menu